Media
- News and more from the frontiers of medicine
Newsroom
AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy
Collaborating to explore new gene regulation therapies
Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.
Expanding CAR-T manufacturing in Europe
European Medicines Agency (EMA) recently approved two European Novartis sites for commercial CAR-T manufacturing.
One Transplant for Life
At Novartis, we aim to extend the life of transplanted organs. A video series provides human perspectives on why this goal means so much to us.
Coronavirus disease (COVID-19) news
Latest media releases and statements in the Novartis Newsroom.
Standing for Racial Equity and Justice as One Novartis
We believe unequivocally that Black Lives Matter. As a company focused on improving human health globally, we also recognize the disparities Black communities and communities of color face when it comes to healthcare.
Live Magazine is now online
Our award-winning in-house magazine is now available in an engaging digital format.
Novartis Media Relations on Twitter #NovartisNews
Find contacts at Novartis for media and journalist inquiries from the general and individual contacts listed below.
-
Satoshi Sugimoto
Communications Europe including Switzerland
- Phone:
- Email: